Testing for prcd-PRA: Progressive Retinal Atrophy in Dogs
Progressive retinal atrophy (PRA) is a hereditary eye condition in dogs that leads to a gradual decline in vision, eventually causing blindness. One common genetic variant, prcd-PRA (progressive rod-cone degeneration), is a leading cause of inherited blindness in many dog breeds across the United States.
Although prcd-PRA does not cause pain, the resulting vision loss has a major impact on a dog's daily life. Since this disorder is passed down genetically, many responsible American breeders now perform routine testing of breeding dogs for prcd-PRA to help reduce its prevalence and protect future litters.
In the U.S., veterinary organizations and breed clubs promote awareness and recommend testing for prcd-PRA, especially in breeds that are genetically predisposed to this condition.
What is prcd-PRA Progressive Retinal Atrophy?
Prcd-PRA is a genetic disease where the retinal cells responsible for detecting light and color—the rods and cones—progressively deteriorate. While affected dogs typically have normal vision at birth, the disease usually begins to manifest between three and five years of age. First, dogs develop night blindness, followed by a gradual loss of vision in daylight that ultimately leads to complete blindness.
This particular form of PRA stems from a mutation called c.5G>A in the PRCD gene. It's important to note that several forms of PRA exist, each linked to distinct genetic mutations, so tests specifically for prcd-PRA target only this known mutation.
Which Dog Breeds Are Prone to prcd-PRA?
Prcd-PRA affects numerous breeds, particularly those with documented genetic risk. Common U.S. breeds susceptible to prcd-PRA include the Labrador Retriever puppies, Labradoodle puppies, Golden Retriever puppies, Standard Poodle puppies, and Cocker Spaniel puppies.
Hybrid or mixed breeds, such as Labradoodles, may also inherit risk genes if their parents carry the mutation. Prospective puppy buyers and breeders in the U.S. are encouraged to consult breed-specific health resources such as the Orthopedic Foundation for Animals (OFA) or the American Kennel Club’s Canine Health Information Center (CHIC) for updated breed health information. However, mixed-breed dogs may lack comprehensive genetic health backgrounds.
How Is prcd-PRA Inherited?
The genetic mutation responsible for prcd-PRA follows an autosomal recessive inheritance pattern. For a dog to develop the disease and experience blindness, it must receive two copies of the mutation—one from each parent.
Dogs with only one copy are carriers: though they usually do not show symptoms, they can transmit the mutation to their puppies. Ethical breeders avoid breeding two carriers together to prevent affected offspring.
What Are the Signs and Symptoms of prcd-PRA?
The earliest sign of prcd-PRA is night blindness, where affected dogs have difficulty seeing in low-light conditions. The vision loss advances slowly, typically beginning around age three but sometimes later in life. Eventually, daytime vision diminishes, leading to full blindness.
Owners may observe their dog hesitating at dusk or in dim lighting, bumping into furniture, or showing reluctance to navigate unfamiliar spaces. As the disease progresses, dogs also lose their ability to see during daylight hours.
How Is Testing for prcd-PRA Done?
Testing involves obtaining a DNA sample, typically from a gentle cheek swab performed by a veterinarian. The sample is then sent to specialized laboratories equipped to detect the prcd-PRA gene mutation.
Several U.S. veterinary labs provide prcd-PRA genetic testing, and many also offer at-home testing kits for owner convenience. Your veterinario can guide you to reputable labs authorized for this testing.
Understanding Test Results
| Result | Genotype | Description | Impact on Puppies |
|---|---|---|---|
| Clear/Normal | N/N | The dog does not carry the prcd-PRA mutation. | Offspring will not inherit prcd-PRA from this dog. |
| Carrier | N/A | The dog has one copy of the mutation but will not develop prcd-PRA. | Can pass the mutation to puppies; breeding two carriers risks affected pups. |
| Affected | A/A | Two copies of the mutation are present; the dog will develop prcd-PRA. | All offspring inherit the mutation and are at risk. |
Why Testing Matters for Breeders and Owners
Genetic testing plays a crucial role in helping breeders make informed choices, avoiding carrier-to-carrier mating and lowering the incidence of prcd-PRA in future generations. This practice helps prevent producing puppies that will suffer from blindness.
Owners of at-risk breeds also benefit by knowing their dog’s genetic status, allowing them to seek early veterinary guidance and manage their pet’s health proactively.
In addition to genetic testing, yearly eye examinations by veterinary ophthalmologists are recommended to assess eye health, as prcd-PRA is just one cause of progressive vision loss.
Summary and Next Steps
Prcd-PRA is a significant inherited retinal disorder causing blindness in many popular U.S. dog breeds. Reliable genetic tests available in the U.S. offer a straightforward, painless way to identify affected dogs and carriers.
Engaging in responsible breeding practices that include prcd-PRA testing can reduce the spread of this disease and enhance canine welfare. If you own or plan to breed a susceptible dog, talk with your veterinario about testing and work closely with reputable breeders to ensure the health of future puppies.
